Short Cuts

What's new in the other general journals

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7495.811 (Published 07 April 2005) Cite this as: BMJ 2005;330:811
  1. Christopher Martyn, associate editor (cmartyn@bmj.com)

    Clopidogrel helps reduce ischaemic complications in acute MI

    Aspirin and fibrinolytic therapy were established as an effective intervention in acute myocardial infarction more than a decade ago, although reperfusion fails to occur in about 20% of treated patients. Improvements have been slow in coming. Antiplatelet therapy with glycoprotein IIb/IIIa inhibitors improved rates of reperfusion and reduced reinfarction but at the unacceptable cost of doubling major bleeds. Now a randomised trial of 3491 patients, all 75 years and under, with ST elevation myocardial infarction finds that the addition of clopidogrel to a standard fibrinolytic regimen improves the patency rate of the artery whose occlusion caused the infarct and reduces ischaemic complications without an increase in adverse events.

    Credit: MEDICINE OF JOURNAL ENGLAND NEW

    The primary endpoint was a composite of occlusion of the relevant artery at angiography, 4-8 days later, or death or further infarction before angiography. It occurred in 21.7% of the placebo group but only 15% of the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe